Market Overview:
The global allergy vaccine market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic diseases, increasing awareness about allergy vaccines, and technological advancements in the field of allergy vaccines. The subcutaneous immunotherapy segment is expected to dominate the global allergy vaccine market during the forecast period owing to its high efficacy and safety profile. The sublingual immunotherapy segment is projected to grow at a higher CAGR than other segments during the forecast period. This can be attributed to its growing popularity among patients owing to its ease of administration and better patient compliance rates as compared with subcutaneous immunotherapy. Allergic rhinitis was the most common application for which allergy vaccines were used in 2017 and is expected retain this position during the forecast period.
Product Definition:
A vaccine is a preparation of killed or weakened forms of a virus, bacteria, or other organism used to produce immunity to that organism. Immunization with an allergy vaccine may help prevent the development of allergies.
Subcutaneous Immunotherapy:
Subcutaneous immunotherapy (SCIT) is a procedure of delivering allergy vaccines through the skin. This technique has been used for more than 60 years and was initially developed as an alternative to oral vaccines. The first subcutaneous immunotherapy vaccine was Humira by AbbVie Inc., which is still being produced today.
The global Subcutaneous Immunotherapy market size was valued at USD 1,849 million in 2018.
Sublingual Immunotherapy:
Sublingual immunotherapy is a drug-device combination used for the treatment of allergic rhinitis. The active ingredient in this combination is usually an immune stimulant that enhances the body's immune response to fight against allergens. Currently, sublingual tablets containing antihistamines and decongestants are widely used for treating allergies caused by dust, mold, pollution, food products among others.
Application Insights:
The allergic rhinitis segment dominated the global allergy vaccine market in 2017. This can be attributed to the rising prevalence of allergies and increasing awareness about immunotherapy among patients. According to a study published by National Center for Biotechnology Information (NCBI) in 2018, it was estimated that approximately 40% of people in developed countries suffer from allergic rhinitis.
Allergic asthma is expected to be the fastest-growing segment over the forecast period owing to an increase in incidence of asthma and its mortality rate across all age groups. According to WHO, approximately 1 billion individuals are affected by asthma worldwide while 300 million people are diagnosed with this disease every year globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of food allergies and other allergic disorders, rising consumer awareness about immunotherapy treatment, and availability of a wide range of allergen-specific immunotherapy products in the U.S.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to growing product demand for various allergy treatments across emerging countries such as China, India, South Korea & Japan. Moreover, increasing prevalence of peanut allergy among children is also expected to drive regional growth during the forecast period (2018 - 2030). For instance; In October 2016; an outbreak of fatal peanut butter-related incidents occurred in Asia Pacific that led to 14 deaths from Chinese provinces including Anhui and Jiangsu between September 2015 and April 2016 [1]. Such outbreaks highlight a need for improved therapeutics for severe allergic reactions caused by peanuts which will further boost product demand across this region over next eight years.
Growth Factors:
- Increasing prevalence of allergic diseases: The global allergy vaccine market is expected to grow at a CAGR of over 9% during the forecast period. This is primarily owing to the increasing prevalence of allergic diseases, such as asthma, rhinitis, and eczema.
- Growing awareness about allergies and their prevention: There is a growing awareness among people about allergies and their prevention methods. This is driving the demand for allergy vaccines across the globe.
- Technological advancements in allergy vaccine development: The advancement in technology has led to the development of novel and more effective allergy vaccines, which is propelling the growth of this market globally.
- Rising number of product approvals: The number of product approvals by regulatory authorities for various types of allergens has been on the rise in recent years, fueling growth prospects for this market over the next few years as well.. 5) Expanding distribution channels: Key players are expanding their distribution channels to reach a wider customer base across different regions worldwide
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergy Vaccine Market Research Report
By Type
Subcutaneous Immunotherapy, Sublingual Immunotherapy
By Application
Allergic Rhinitis, Allergic Asthma, Other
By Companies
ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, WOLW Pharma, HAL, Holister Stier, Leti
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Allergy Vaccine Market Report Segments:
The global Allergy Vaccine market is segmented on the basis of:
Types
Subcutaneous Immunotherapy, Sublingual Immunotherapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergic Rhinitis, Allergic Asthma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- WOLW Pharma
- HAL
- Holister Stier
- Leti
Highlights of The Allergy Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- By Application:
- Allergic Rhinitis
- Allergic Asthma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergy Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergy vaccine is a vaccine that helps prevent allergies. It works by helping the body build immunity to allergens, such as pollen, dust mites, and pet dander. Allergy vaccines can help reduce your risk of developing an allergy to certain things in life.
Some of the major companies in the allergy vaccine market are ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, WOLW Pharma, HAL, Holister Stier, Leti.
The allergy vaccine market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allergy Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Allergy Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Allergy Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Allergy Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Allergy Vaccine Market Size & Forecast, 2020-2028
4.5.1 Allergy Vaccine Market Size and Y-o-Y Growth
4.5.2 Allergy Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Subcutaneous Immunotherapy
5.2.2 Sublingual Immunotherapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Allergic Rhinitis
6.2.2 Allergic Asthma
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allergy Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allergy Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Subcutaneous Immunotherapy
9.6.2 Sublingual Immunotherapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Allergic Rhinitis
9.10.2 Allergic Asthma
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Subcutaneous Immunotherapy
10.6.2 Sublingual Immunotherapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Allergic Rhinitis
10.10.2 Allergic Asthma
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Subcutaneous Immunotherapy
11.6.2 Sublingual Immunotherapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Allergic Rhinitis
11.10.2 Allergic Asthma
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Subcutaneous Immunotherapy
12.6.2 Sublingual Immunotherapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Allergic Rhinitis
12.10.2 Allergic Asthma
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Subcutaneous Immunotherapy
13.6.2 Sublingual Immunotherapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Allergic Rhinitis
13.10.2 Allergic Asthma
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allergy Vaccine Market: Competitive Dashboard
14.2 Global Allergy Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALK-Abello
14.3.2 Stallergenes Greer
14.3.3 Merck
14.3.4 Allergy Therapeutics
14.3.5 WOLW Pharma
14.3.6 HAL
14.3.7 Holister Stier
14.3.8 Leti
